RenovoRx (RNXT) Change in Inventory (2025 - 2026)
RenovoRx's (RNXT) quarterly Change in Inventory came in at $4000.0 in Q2 2026, down 97.89% quarter-over-quarter from $190000.0 in Q1 2026.
Analysis
RenovoRx (RNXT) Change in Inventory (2025 - 2026) Analysis & Trends
RenovoRx has disclosed Change in Inventory across 2 years of filings, most recently posting $4000.0 for Q2 2026.
- In Q2 2026, Change in Inventory changed N/A year-over-year to $4000.0; the TTM figure through Jun 2026 stood at $383000.0 (changed N/A YoY), while the FY2025 annual figure was $189000.0, changed N/A from the prior year.
- Change in Inventory came in at $4000.0 for Q2 2026 at RenovoRx, down from $190000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $272000.0 in Q3 2025 to a low of -$83000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 301.00 Mn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 248.00 Mn |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn | 240.00 Mn |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn | 113.00 Mn |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn | 133.00 Mn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn | 23.50 Mn |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn | 36.40 Mn |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn | 73.30 Mn |
| 10 | RenovoRx | 83.24 Mn | 83.24 Mn | 766,000.00 | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | -83,000.00 |
| Sep 30, 2025 | 272,000.00 |